nodes	percent_of_prediction	percent_of_DWPC	metapath
Arbutamine—ADRB3—polycystic ovary syndrome	0.629	0.724	CbGaD
Arbutamine—ADRB2—polycystic ovary syndrome	0.239	0.275	CbGaD
Arbutamine—Mirabegron—ADRB3—polycystic ovary syndrome	0.00091	0.113	CrCbGaD
Arbutamine—Fenoterol—ADRB3—polycystic ovary syndrome	0.000801	0.0999	CrCbGaD
Arbutamine—Labetalol—ADRB3—polycystic ovary syndrome	0.000531	0.0663	CrCbGaD
Arbutamine—Norepinephrine—ADRA1D—polycystic ovary syndrome	0.000403	0.0503	CrCbGaD
Arbutamine—Isoprenaline—ADRB3—polycystic ovary syndrome	0.000391	0.0488	CrCbGaD
Arbutamine—Epinephrine—ADRA1D—polycystic ovary syndrome	0.000366	0.0456	CrCbGaD
Arbutamine—Norepinephrine—ADRB3—polycystic ovary syndrome	0.000362	0.0452	CrCbGaD
Arbutamine—Masoprocol—CYP19A1—polycystic ovary syndrome	0.000347	0.0432	CrCbGaD
Arbutamine—Norepinephrine—ADRA1B—polycystic ovary syndrome	0.000344	0.0429	CrCbGaD
Arbutamine—Epinephrine—ADRB3—polycystic ovary syndrome	0.000329	0.041	CrCbGaD
Arbutamine—Salmeterol—ADRB2—polycystic ovary syndrome	0.000316	0.0394	CrCbGaD
Arbutamine—Epinephrine—ADRA1B—polycystic ovary syndrome	0.000312	0.0389	CrCbGaD
Arbutamine—Ritodrine—ADRB2—polycystic ovary syndrome	0.000305	0.038	CrCbGaD
Arbutamine—Fenoterol—ADRB2—polycystic ovary syndrome	0.000305	0.038	CrCbGaD
Arbutamine—Arformoterol—ADRB2—polycystic ovary syndrome	0.000277	0.0345	CrCbGaD
Arbutamine—Formoterol—ADRB2—polycystic ovary syndrome	0.000277	0.0345	CrCbGaD
Arbutamine—Dobutamine—ADRB2—polycystic ovary syndrome	0.000262	0.0327	CrCbGaD
Arbutamine—Norepinephrine—ADRA1A—polycystic ovary syndrome	0.000232	0.0289	CrCbGaD
Arbutamine—Epinephrine—ADRA1A—polycystic ovary syndrome	0.00021	0.0262	CrCbGaD
Arbutamine—Labetalol—ADRB2—polycystic ovary syndrome	0.000202	0.0252	CrCbGaD
Arbutamine—Isoprenaline—ADRB2—polycystic ovary syndrome	0.000149	0.0185	CrCbGaD
Arbutamine—Norepinephrine—ADRB2—polycystic ovary syndrome	0.000138	0.0172	CrCbGaD
Arbutamine—Isoprenaline—CYP1A1—polycystic ovary syndrome	0.000128	0.0159	CrCbGaD
Arbutamine—Epinephrine—ADRB2—polycystic ovary syndrome	0.000125	0.0156	CrCbGaD
Arbutamine—ADRB3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.52e-05	0.000767	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	9.36e-05	0.000754	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—SCT—polycystic ovary syndrome	9.34e-05	0.000753	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	9.29e-05	0.000749	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	9.29e-05	0.000749	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	9.15e-05	0.000738	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	9.14e-05	0.000737	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	9.1e-05	0.000733	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	9.09e-05	0.000732	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	9.09e-05	0.000732	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	9.08e-05	0.000731	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—LHB—polycystic ovary syndrome	9.05e-05	0.000729	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	8.94e-05	0.000721	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.94e-05	0.00072	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.91e-05	0.000718	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	8.88e-05	0.000715	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	8.85e-05	0.000713	CbGpPWpGaD
Arbutamine—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	8.77e-05	0.000707	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	8.69e-05	0.0007	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	8.5e-05	0.000685	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—SCT—polycystic ovary syndrome	8.48e-05	0.000683	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	8.44e-05	0.00068	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	8.44e-05	0.00068	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	8.44e-05	0.00068	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.4e-05	0.000677	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.4e-05	0.000677	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	8.25e-05	0.000665	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	8.25e-05	0.000665	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	8.25e-05	0.000665	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	8.21e-05	0.000661	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	8.09e-05	0.000652	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	8.03e-05	0.000647	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.9e-05	0.000637	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	7.89e-05	0.000636	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.85e-05	0.000633	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	7.72e-05	0.000622	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	7.66e-05	0.000617	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.62e-05	0.000614	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	7.51e-05	0.000605	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	7.49e-05	0.000604	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	7.47e-05	0.000602	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	7.45e-05	0.0006	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.42e-05	0.000598	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	7.3e-05	0.000588	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	7.29e-05	0.000587	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—INHBB—polycystic ovary syndrome	7.23e-05	0.000582	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	6.91e-05	0.000557	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	6.83e-05	0.00055	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	6.8e-05	0.000548	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	6.78e-05	0.000546	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	6.76e-05	0.000545	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.75e-05	0.000544	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	6.68e-05	0.000538	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	6.65e-05	0.000536	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	6.63e-05	0.000534	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.58e-05	0.00053	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	6.22e-05	0.000501	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	6.17e-05	0.000498	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—FSHR—polycystic ovary syndrome	6.15e-05	0.000495	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	6.08e-05	0.00049	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	6.04e-05	0.000487	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—POMC—polycystic ovary syndrome	6.02e-05	0.000485	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	5.99e-05	0.000482	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.98e-05	0.000481	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	5.97e-05	0.000481	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	5.92e-05	0.000477	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	5.86e-05	0.000472	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	5.84e-05	0.000471	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	5.79e-05	0.000466	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	5.78e-05	0.000466	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.78e-05	0.000466	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	5.72e-05	0.000461	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	5.66e-05	0.000456	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	5.65e-05	0.000455	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.62e-05	0.000453	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	5.54e-05	0.000447	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	5.52e-05	0.000445	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—FST—polycystic ovary syndrome	5.48e-05	0.000441	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.45e-05	0.000439	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	5.44e-05	0.000438	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	5.42e-05	0.000437	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	5.4e-05	0.000435	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	5.37e-05	0.000433	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—LHB—polycystic ovary syndrome	5.35e-05	0.000431	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	5.32e-05	0.000429	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	5.3e-05	0.000427	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	5.29e-05	0.000426	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	5.28e-05	0.000426	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	5.25e-05	0.000423	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	5.25e-05	0.000423	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.23e-05	0.000421	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	5.19e-05	0.000418	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	5.17e-05	0.000417	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	5.14e-05	0.000414	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	5.06e-05	0.000408	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	5.05e-05	0.000407	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	5.03e-05	0.000406	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—SCT—polycystic ovary syndrome	5.01e-05	0.000404	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.98e-05	0.000402	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.98e-05	0.000402	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.95e-05	0.000399	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	4.92e-05	0.000397	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	4.88e-05	0.000393	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	4.88e-05	0.000393	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	4.8e-05	0.000387	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.78e-05	0.000385	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	4.7e-05	0.000379	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—FGF18—polycystic ovary syndrome	4.7e-05	0.000378	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	4.69e-05	0.000378	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	4.66e-05	0.000376	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—RBP4—polycystic ovary syndrome	4.66e-05	0.000375	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	4.59e-05	0.00037	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.59e-05	0.00037	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	4.56e-05	0.000367	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	4.53e-05	0.000365	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	4.43e-05	0.000357	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.4e-05	0.000355	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—YAP1—polycystic ovary syndrome	4.35e-05	0.00035	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	4.31e-05	0.000347	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	4.29e-05	0.000346	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—GAB1—polycystic ovary syndrome	4.29e-05	0.000346	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	4.2e-05	0.000338	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—INSR—polycystic ovary syndrome	4.1e-05	0.00033	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	4.01e-05	0.000323	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.92e-05	0.000316	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.91e-05	0.000315	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.9e-05	0.000314	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.84e-05	0.000309	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.82e-05	0.000308	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PGR—polycystic ovary syndrome	3.8e-05	0.000306	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	3.65e-05	0.000294	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	3.57e-05	0.000288	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	3.57e-05	0.000288	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.55e-05	0.000286	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—GHRL—polycystic ovary syndrome	3.53e-05	0.000284	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PLAT—polycystic ovary syndrome	3.53e-05	0.000284	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	3.49e-05	0.000282	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.47e-05	0.00028	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.43e-05	0.000276	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.4e-05	0.000274	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ATF1—polycystic ovary syndrome	3.37e-05	0.000271	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.35e-05	0.00027	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.34e-05	0.000269	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.28e-05	0.000265	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.27e-05	0.000263	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.26e-05	0.000263	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	3.25e-05	0.000262	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.23e-05	0.00026	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.21e-05	0.000259	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	3.18e-05	0.000256	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	3.17e-05	0.000256	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.14e-05	0.000253	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NGFR—polycystic ovary syndrome	3.11e-05	0.00025	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	3.1e-05	0.00025	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.1e-05	0.00025	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—POMC—polycystic ovary syndrome	3.09e-05	0.000249	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PRL—polycystic ovary syndrome	3.08e-05	0.000248	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.03e-05	0.000244	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3e-05	0.000242	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3e-05	0.000242	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	2.97e-05	0.00024	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.97e-05	0.000239	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.94e-05	0.000237	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.94e-05	0.000237	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.93e-05	0.000236	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.92e-05	0.000235	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	2.91e-05	0.000234	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.84e-05	0.000229	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	2.79e-05	0.000225	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.78e-05	0.000224	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	2.76e-05	0.000223	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	2.73e-05	0.00022	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.72e-05	0.000219	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.71e-05	0.000218	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	2.7e-05	0.000218	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.66e-05	0.000215	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.58e-05	0.000208	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	2.58e-05	0.000208	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	2.55e-05	0.000205	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.53e-05	0.000204	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	2.52e-05	0.000203	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	2.49e-05	0.000201	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	2.43e-05	0.000196	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	2.38e-05	0.000192	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.31e-05	0.000186	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.28e-05	0.000183	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.26e-05	0.000182	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	2.25e-05	0.000182	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.23e-05	0.000179	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	2.2e-05	0.000178	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.17e-05	0.000175	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—LEP—polycystic ovary syndrome	2.12e-05	0.000171	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	2.1e-05	0.000169	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	2.1e-05	0.000169	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	2.05e-05	0.000165	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	2.05e-05	0.000165	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.02e-05	0.000163	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	2e-05	0.000161	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.97e-05	0.000159	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	1.96e-05	0.000158	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.95e-05	0.000157	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.94e-05	0.000156	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.91e-05	0.000154	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.9e-05	0.000153	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.89e-05	0.000153	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.84e-05	0.000149	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	1.83e-05	0.000148	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	1.83e-05	0.000147	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—POMC—polycystic ovary syndrome	1.82e-05	0.000147	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—INS—polycystic ovary syndrome	1.81e-05	0.000146	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	1.8e-05	0.000145	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	1.79e-05	0.000144	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	1.79e-05	0.000144	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.76e-05	0.000142	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.75e-05	0.000141	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.75e-05	0.000141	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.73e-05	0.00014	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.72e-05	0.000139	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.67e-05	0.000134	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	1.61e-05	0.00013	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	1.57e-05	0.000127	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.53e-05	0.000123	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	1.5e-05	0.000121	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.5e-05	0.000121	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.47e-05	0.000119	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.34e-05	0.000108	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.29e-05	0.000104	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	1.26e-05	0.000102	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.26e-05	0.000102	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	1.23e-05	9.93e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.15e-05	9.24e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.12e-05	9.06e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.1e-05	8.86e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.08e-05	8.72e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.08e-05	8.68e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.06e-05	8.53e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.05e-05	8.49e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.04e-05	8.39e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.04e-05	8.39e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.02e-05	8.21e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.02e-05	8.2e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.89e-06	7.97e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.67e-06	7.8e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.96e-06	6.42e-05	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IL6—polycystic ovary syndrome	7.93e-06	6.39e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	7.79e-06	6.28e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.8e-06	5.48e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.65e-06	5.36e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	4.7e-06	3.79e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	4.6e-06	3.71e-05	CbGpPWpGaD
